심현정
#담관암#대장암#두경부종양#식도암#위암#유방암#직장암#췌장암#호스피스완화의료#흑색종
|
학력
2002. 02. 전남대학교 의과대학 학사
2005. 02. 전남대학교 의과대학 석사
2009. 02. 전남대학교 의과대학 학사 의학박사
2005. 02. 전남대학교 의과대학 석사
2009. 02. 전남대학교 의과대학 학사 의학박사
경력
2007. 03. ~ 2008. 02. 전남대학교 혈액종양내과 분과전임의
2008. 03. ~ 2010. 02. 전남대학교 혈액종양내과 임상전임강사
2010. 03. ~ 2014. 08. 전남대학교 혈액종양내과 임상조교수
2014. 09. ~ 현재 전남대학교 혈액종양내과 조교수
2008. 03. ~ 2010. 02. 전남대학교 혈액종양내과 임상전임강사
2010. 03. ~ 2014. 08. 전남대학교 혈액종양내과 임상조교수
2014. 09. ~ 현재 전남대학교 혈액종양내과 조교수
논문
2018 Lee JK, Lee KH, Kim SA1, Kweon SS, Cho SH, Shim HJ, Bae WK, Chung IJ, Chung WK5, Yoon TM1, Lim SC1, Lee DH1. p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma. Oncol Lett. 2018 May;15(5):6571-6577.
2018 Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH. Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey. Support Care Cancer. 2018 Apr 22.
2018 Yoo SH, Kim M, Yun YH, Keam B, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Kim SY, Kang EJ, Do YR, Choi YS, Jung KH. Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.Cancer Med. 2018 May;7(5):1784-1793.
2018 Bae WK, Hong CS, Park MR, Sun EG, Lee JH, Kang K, Ryu KH, Shim HJ, Hwang JE, Cho SH, Chung IJ. TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma. Cancer Lett. 2018 Feb 28;415:106-116
2018 Moon KR, Choi YD, Kim JM, Jin S, Shin MH, Shim HJ, Lee JB, Yun SJ. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features. J Invest Dermatol. 2018 Apr;138(4):933-945
2017 Hwang JE, Ki MS, Kim K, Jung SH, Shim HJ, Bae WK, Hwang EC, Hur YH, Jeong O, Ryu SY, Park YK, Cho SH, Lee JS, Chung IJ. The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget. 2017 Mar 16;8(39):66559-66568
2018 Kim KR, Shim HJ, Hwang JE, Cho SH, Chung IJ, Park KS, Kang SR, Kwon SY, Chung WK, Bae WK. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):170-178
2017 Kim KR, Yoon JH, Shim HJ, Hwang JE, Bae WK, Chung IJ, Kim HN, Shin MH, Cho SH. Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer. Oncol Lett. 2017 Aug;14(2):2491-2498
2017 Cho SH, Hong CS, Kim HN, Shin MH, Kim KR, Shim HJ, Hwang JE, Bae WK, Chung IJ. FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition. Cancer Res Treat. 2017 Jul;49(3):766-777
2016 Shim HJ, Lee R, Shin MH, Kim HN, Kweon SS.Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses. Cancer Res Treat. 2016 Nov 9. doi: 10.4143/crt.2016.457. [Epub ahead of print]
2016 Shim HJ, Shin MH, Kim HN, Kim JH, Hwang JE, Bae WK, Chung IJ, Cho SH.The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy. Cancer Res Treat. 2016 Jan;48(1):71-9. doi: 10.4143/crt.2015.018.
2016 Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, Nam TK, Chung IJ, Cho SH.A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2.
2015 Shim HJ, Lee R, Shin MH, Kim HN, Cho D, Ahn HR, Kweon SS. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans. Asian Pac J Cancer Prev. 2015;16(7):2771-5.
2012 Kim HN, Kim DE, Hwang JE, Bae WK, Cho SH, Joo YE, Choi KH, Chung IJ, Shim HJ.Paradoxical cerebral embolism during endoscopic esophageal stenting in a patient with esophageal cancer. Endoscopy. 2012 Dec;44 Suppl 2 UCTN:E406-7.
2012 Shim HJ, Kim DE, Hwang JE, Bae WK, Nam TK, Na KJ, Cho SH, Chung IJ. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer.Cancer Chemother Pharmacol. 2012 Nov;70(5):683-90.
2011 Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Chung IJ. Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer. Gastric Cancer. 2011 Mar 23
2010 Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, Kim HN, Shin MH, Kweon SS, Lee JH, Kim HJ, Chung IJ. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci. 2010 May;101(5):1247-54. Epub 2010 Mar 12.
2010 Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer. Am J Clin Oncol. 2010 Dec;33(6):624-8.
2010 Shim HJ. Tertiary syphilis mimicking hepatic metastases of underlying primary peritoneal serous carcinoma. World J Hepatol. 2010 Sep 27;2(9):362-6.
2011 Yhim HY, Lee NR, Song EK, Kwak JY, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer. 2011 Oct 1;129(7):1752-60. doi: 10.1002/ijc.25825. Epub 2011 Feb 26.
2011 Bae WK, Lee JH, Lee SJ, Park MS, Hwang JE, Shim HJ, Cho SH, Guo DD, Cho CS, Park IK, Chung IJ. Enhanced anti-cancer effect of 5-fluorouracil loaded into thermo-responsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models. J Nanosci Nanotechnol. 2011 Feb;11(2):1425-8.
2010 Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ. Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity. Cancer Res Treat. 2010 Mar;42(1):37-41. Epub 2010 Mar 31.
2009 Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Cho SH, Lee JJ, Kim HJ, Chung IJ. Metastatic breast cancer presenting as cancer of unknown primary associated with superior vena cava syndrome. Breast J. 2009 Mar-Apr;15(2):202-3
2010 Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, Chung WK, Chung IJ. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol. 2010 Feb;65(3):589-95.
2010 Kim YI, Yoon JY, Hwang JE, Shim HJ, Bae WK, Cho SH, Chung IJ. Reversible proximal renal tubular dysfunction after one-time Ifosfamide exposure. Cancer Res Treat. 2010 Dec;42(4):244-6. Epub 2010 Dec 31.
2008 Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Nam TK, Lee JJ, Kim HJ, Chung IJ. Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. Dis Esophagus. 2008;21(8):697-703. Epub 2008 Jun 2.
2008 Hwang JE, Cho SH, Kim OK, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone. J Korean Med Sci. 2008 Jun;23(3):544-7.
2006 Shim HJ, Lim JH, Lee S, Kim DH, Park KJ, Lee SR, Jeong JP, Son JG, Kim SO, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, Kim SM, Na KJ. Primary Endobronchial Leiomyoma Combined with Uterine Leiomyoma. Tuberc Respir Dis. 2006 Nov;61(5):490-495.
2006 Shim HJ, Cho SH, Lee JK, Ahn JS, Yang DH, Kim YK, Chung IJ. A case of extensive hemorrhagic colitis after docetaxel-based combination chemotherapy. Korean J Med. 2006 Feb;70(2):207-21
2018 Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH. Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey. Support Care Cancer. 2018 Apr 22.
2018 Yoo SH, Kim M, Yun YH, Keam B, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Kim SY, Kang EJ, Do YR, Choi YS, Jung KH. Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.Cancer Med. 2018 May;7(5):1784-1793.
2018 Bae WK, Hong CS, Park MR, Sun EG, Lee JH, Kang K, Ryu KH, Shim HJ, Hwang JE, Cho SH, Chung IJ. TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma. Cancer Lett. 2018 Feb 28;415:106-116
2018 Moon KR, Choi YD, Kim JM, Jin S, Shin MH, Shim HJ, Lee JB, Yun SJ. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features. J Invest Dermatol. 2018 Apr;138(4):933-945
2017 Hwang JE, Ki MS, Kim K, Jung SH, Shim HJ, Bae WK, Hwang EC, Hur YH, Jeong O, Ryu SY, Park YK, Cho SH, Lee JS, Chung IJ. The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget. 2017 Mar 16;8(39):66559-66568
2018 Kim KR, Shim HJ, Hwang JE, Cho SH, Chung IJ, Park KS, Kang SR, Kwon SY, Chung WK, Bae WK. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):170-178
2017 Kim KR, Yoon JH, Shim HJ, Hwang JE, Bae WK, Chung IJ, Kim HN, Shin MH, Cho SH. Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer. Oncol Lett. 2017 Aug;14(2):2491-2498
2017 Cho SH, Hong CS, Kim HN, Shin MH, Kim KR, Shim HJ, Hwang JE, Bae WK, Chung IJ. FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition. Cancer Res Treat. 2017 Jul;49(3):766-777
2016 Shim HJ, Lee R, Shin MH, Kim HN, Kweon SS.Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses. Cancer Res Treat. 2016 Nov 9. doi: 10.4143/crt.2016.457. [Epub ahead of print]
2016 Shim HJ, Shin MH, Kim HN, Kim JH, Hwang JE, Bae WK, Chung IJ, Cho SH.The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy. Cancer Res Treat. 2016 Jan;48(1):71-9. doi: 10.4143/crt.2015.018.
2016 Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, Nam TK, Chung IJ, Cho SH.A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2.
2015 Shim HJ, Lee R, Shin MH, Kim HN, Cho D, Ahn HR, Kweon SS. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans. Asian Pac J Cancer Prev. 2015;16(7):2771-5.
2012 Kim HN, Kim DE, Hwang JE, Bae WK, Cho SH, Joo YE, Choi KH, Chung IJ, Shim HJ.Paradoxical cerebral embolism during endoscopic esophageal stenting in a patient with esophageal cancer. Endoscopy. 2012 Dec;44 Suppl 2 UCTN:E406-7.
2012 Shim HJ, Kim DE, Hwang JE, Bae WK, Nam TK, Na KJ, Cho SH, Chung IJ. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer.Cancer Chemother Pharmacol. 2012 Nov;70(5):683-90.
2011 Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Chung IJ. Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer. Gastric Cancer. 2011 Mar 23
2010 Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, Kim HN, Shin MH, Kweon SS, Lee JH, Kim HJ, Chung IJ. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci. 2010 May;101(5):1247-54. Epub 2010 Mar 12.
2010 Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer. Am J Clin Oncol. 2010 Dec;33(6):624-8.
2010 Shim HJ. Tertiary syphilis mimicking hepatic metastases of underlying primary peritoneal serous carcinoma. World J Hepatol. 2010 Sep 27;2(9):362-6.
2011 Yhim HY, Lee NR, Song EK, Kwak JY, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer. 2011 Oct 1;129(7):1752-60. doi: 10.1002/ijc.25825. Epub 2011 Feb 26.
2011 Bae WK, Lee JH, Lee SJ, Park MS, Hwang JE, Shim HJ, Cho SH, Guo DD, Cho CS, Park IK, Chung IJ. Enhanced anti-cancer effect of 5-fluorouracil loaded into thermo-responsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models. J Nanosci Nanotechnol. 2011 Feb;11(2):1425-8.
2010 Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ. Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity. Cancer Res Treat. 2010 Mar;42(1):37-41. Epub 2010 Mar 31.
2009 Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Cho SH, Lee JJ, Kim HJ, Chung IJ. Metastatic breast cancer presenting as cancer of unknown primary associated with superior vena cava syndrome. Breast J. 2009 Mar-Apr;15(2):202-3
2010 Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, Chung WK, Chung IJ. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol. 2010 Feb;65(3):589-95.
2010 Kim YI, Yoon JY, Hwang JE, Shim HJ, Bae WK, Cho SH, Chung IJ. Reversible proximal renal tubular dysfunction after one-time Ifosfamide exposure. Cancer Res Treat. 2010 Dec;42(4):244-6. Epub 2010 Dec 31.
2008 Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Nam TK, Lee JJ, Kim HJ, Chung IJ. Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. Dis Esophagus. 2008;21(8):697-703. Epub 2008 Jun 2.
2008 Hwang JE, Cho SH, Kim OK, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone. J Korean Med Sci. 2008 Jun;23(3):544-7.
2006 Shim HJ, Lim JH, Lee S, Kim DH, Park KJ, Lee SR, Jeong JP, Son JG, Kim SO, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, Kim SM, Na KJ. Primary Endobronchial Leiomyoma Combined with Uterine Leiomyoma. Tuberc Respir Dis. 2006 Nov;61(5):490-495.
2006 Shim HJ, Cho SH, Lee JK, Ahn JS, Yang DH, Kim YK, Chung IJ. A case of extensive hemorrhagic colitis after docetaxel-based combination chemotherapy. Korean J Med. 2006 Feb;70(2):207-21
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.